GSK study suggests its antidepressant drugs cause suicidal tendencies

Published in the Journal of Clinical Psychiatry, the GSK study reveals a nearly sevenfold increase in suicide attempts among those taking Paxil versus those taking a placebo. In clinical trials, 0.34 percent of participants taking Paxil attempted suicide, while only 0.05 percent of those taking a placebo did.

Besides increasing the risk of suicidal tendencies, a GSK study published in the Journal of the American Medical Association in early 2010 showed that Paxil does not even appear to work as intended in patients with varying levels depression.  link